GENCURIX products

Multigene prognostic test predicts the probability of metastasis or recurrence, which helps patients make treatment decision. It improves quality of life for cancer patients as preventing them from unnecessary chemotherapy.

Chemotherapy drugs have many side effects such as reduction in white blood cells, hair loss, vomiting because they attack rapidly growing cells without separating cancer cells from normal cells. However targeted therapy drugs have less side effects because they detect and attack specific targets that exist only in cancer cells.

These tests detect DNA mutations by analyzing certain genes extracted from the patient`s blood and tumor samples based on ddPCR platform which is optimized for companion diagnostics. They select patients who benefit the effectiveness of cancer treatment.

What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal matters.

What is this test? GenePro COVID-19 Detection Test is developed based on “WHO interim guidance for laboratory testing for 2019 novel coronavirus (SARS-CoV-2) in humans” by WHO (World Health Organization), and qualitatively detects RdRP gene / E gene simultaneously. RdRP gene has specific sequence from COVID-19 and E gene is common sequence within corona viruses. The validity of RT-PCR reaction is confirmed by using RNA templet (SARS-CoV-2) as Positive control.

What is this test? GenePro SARS-CoV-2 Test kit is developed to enable high throughput analysis and ?exibility in test numbers for a single run. It allows qualitative detection of Orf1-ab gene / E gene simultaneously. Orf1-ab gene has speci?c sequence from SARS-CoV-2 and E gene is common sequence within coronaviruses. The validity of RT-PCR reaction is con?rmed by using RNA templete(SARS-CoV-2) as positive control.

CTCs(Circulating Tumor Cells) are cancer cells found in blood during metastasis. Being very rare, with one CTC per one billion hematopoietic cells, highly specific and sensitive technologies are imperative for their isolation. Geno CTC ver.3 allow high throughput and more accurate separation of CTCs from whole blood. Effective isolation of CTCs can be extensively used for personalized care through non-invasive liquid biopsy.

GenePro LAMP Test Solution is to facilitate on-site testing for rapid, convenient and simple detection of various infectious diseases. GenePro LAMP SARS-CoV-2 Test Kit can be offered as a package with GenePro LAMP cycler and GenePro VTM. A total solution can be available from sample collection to real-time LAMP testing. GenePro LAMP Test allows rapid point-of-care detection of target genes with portable LAMP cycler which allows to check the test results in real time on the spot without any restrictions of location or space.

GenePro LAMP SARS-CoV-2 Test kit is a real-time reverse transcription loop mediated isothermal amplification (real-time RT-LAMP) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens including oropharyngeal and nasopharyngeal swab, from individuals suspected of COVID-19 by their healthcare provider. It allows qualitative detection of RdRp gene and N gene simultaneously. RdRp gene has specific sequence from SARS-CoV-2 and N gene is common sequence within coronaviruses.

GenePro VTM (GenePro Viral Transport Medium/GenePro Rapid Extraction VTM) is a ready-to-use virus transport medium with a collection swab. It allows safe transfer of viruses from samples collected from upper respiratory tract.